VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
SPRO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
SPROSpero Therapeutics, Inc.
$0.90$52M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSPROQuarterly Cash Flow

Spero Therapeutics, Inc. (SPRO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Spero Therapeutics, Inc. (SPRO) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

SPRO Cash Flow Statement

Quarterly statement

SPRO Cash Flow Statement

Spero Therapeutics, Inc. (SPRO) cash flow statement — 11-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Cash from Operations-42.61M-5.36M15.86M-8.35M17.42M-17.69M-4M-23.4M12.76M-18.74M5.94M-17.49M15.91M-18.56M-12.85M44.48M-957K-23.03M-28.22M-27.35M
Operating CF Margin %--6148.84%-21.06%571.59%-149.92%-68.13%-155.55%94.76%-183.82%141.25%-23.79%62.48%-683.51%-621.22%95.96%-88.45%-2570.65%-11426.32%-996.68%
Operating CF Growth %-344.56%69.73%496.4%64.31%36.5%5.61%-167.4%-33.77%-19.81%-0.97%146.2%-139.33%1763.01%19.4%54.46%262.65%80.67%-39.03%-82.33%-66.94%
Net Income-44.28M-9.55M-7.2M31.52M-7.38M-1.7M-13.87M-20.89M-17.15M-17.86M-12.67M51.19M-3.21M-11.91M-13.27M26.77M-11.68M-28.68M-32.83M-29.24M
Depreciation & Amortization0000500500500002K038K108K108K113K129K257K291K189K191K
Stock-Based Compensation1.68M01.11M1.01M1.05M714K1.56M1.5M2.15M2.11M2.02M2M1.91M1.86M2.17M2.5M2.11M03.2M2.93M
Deferred Taxes0000000000000000000-154K
Other Non-Cash Items2.69M1.05M226K214K869.5K277.5K272.5K268K263K258K254K249K5.55M240K236K93K890K4.03M2.9M1.76M
Working Capital Changes-2.69M3.15M21.73M-41.09M22.89M-16.98M8.04M-4.28M27.49M-3.25M16.33M-70.97M11.55M-8.86M-2.11M14.99M7.46M1.33M-1.69M-2.83M
Change in Receivables13K19K-16K1.56M869K-1.79M2.42M-389K2.04M283K-3.47M1.44M-901K-223K-781K-131K624K393K00
Change in Inventory000000000000000131K0000
Change in Payables256K-62K-476K-702K615K-985K-5.54M1.22M3.39M-370K1.69M275K-207K727K-34K-1.97M871K-3.07M3.68M-2.06M
Cash from Investing00000000000000033.94M-129K50M-16.06M-23.27M
Capital Expenditures000000000000000-129K00039K
CapEx % of Revenue---------------0.28%---1.42%
Acquisitions00000000000000000000
Investments--------------------
Other Investing000000000000000258K-129K000
Cash from Financing99.76M00000000001K220K0014.18M6.13M-53.68M3.81M50.35M
Debt Issued (Net)99.76M0000000000000000-54.48M00
Equity Issued (Net)000000000001K220K0014.18M6.13M808K3.63M2.47M
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing0000000000000001K00188K47.88M
Net Change in Cash57.15M-5.36M15.86M-8.35M17.42M-17.69M-4M-23.4M12.76M-18.74M5.94M-17.49M16.14M-18.56M-12.85M58.66M5.04M-26.71M-40.47M-275K
Free Cash Flow-42.61M-5.36M15.86M-8.35M17.42M-17.69M-4M-23.4M12.76M-18.74M5.94M-17.49M15.91M-18.56M-12.85M44.35M-957K-23.03M-28.22M-27.31M
FCF Margin %--6148.84%-21.06%571.59%-149.92%-68.13%-155.55%94.76%-183.82%141.25%-23.79%62.48%-683.51%-621.22%95.68%-88.45%-2570.65%-11426.32%-995.26%
FCF Growth %-344.56%69.73%496.4%64.31%36.5%5.61%-167.4%-33.77%-19.81%-0.97%146.2%-139.44%1763.01%19.4%54.46%262.41%80.67%-39.03%-82.33%-66.58%
FCF per Share-0.73-0.090.28-0.140.31-0.32-0.07-0.430.24-0.350.11-0.330.30-0.35-0.240.91-0.03-0.70-0.87-0.85
FCF Conversion (FCF/Net Income)0.96x0.56x-2.20x-0.26x-2.36x10.41x0.29x1.12x-0.74x1.05x-0.47x-0.34x-4.97x1.56x0.97x1.66x0.08x0.80x0.86x0.94x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000